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abstractBACKGROUND: Lower weight has historically been equated with more severe illness in anorexia
nervosa (AN). Reliance on admission weight to guide clinical concern is challenged by the rise
in patients with atypical anorexia nervosa (AAN) requiring hospitalization at normal weight.
METHODS: We examined weight history and illness severity in 12- to 24-year-olds with AN (n =
66) and AAN (n = 50) in a randomized clinical trial, the Study of Refeeding to Optimize
Inpatient Gains (www.clinicaltrials.gov; NCT02488109). Amount of weight loss was the
difference between the highest historical percentage median BMI and admission; rate was the
amount divided by duration (months). Unpaired t tests compared AAN and AN; multiple
variable regressions examined associations between weight history variables and markers of
illness severity at admission. Stepwise regression examined the explanatory value of weight
and menstrual history on selected markers.
RESULTS: Participants were 16.5 6 2.6 years old, and 91% were of female sex. Groups did not
differ by weight history or admission heart rate (HR). Eating Disorder Examination
Questionnaire global scores were higher in AAN (mean 3.80 [SD 1.66] vs mean 3.00 [SD 1.66];
P = .02). Independent of admission weight, lower HR (b = 20.492 [confidence interval (CI)
20.883 to 20.100]; P = .01) was associated with faster loss; lower serum phosphorus was
associated with a greater amount (b = 20.005 [CI 20.010 to 0.000]; P = .04) and longer
duration (b =20.011 [CI20.017 to 0.005]; P = .001). Weight and menstrual history explained
28% of the variance in HR and 36% of the variance in serum phosphorus.
CONCLUSIONS: Weight history was independently associated with markers of malnutrition in
inpatients with restrictive eating disorders across a range of body weights and should be
considered when assessing illness severity on hospital admission.
WHAT’S KNOWN ON THIS SUBJECT: Lower weight was
traditionally equated with more severe illness in anorexia
nervosa. The rapid rise in patients with atypical anorexia nervosa
who require hospitalization at normal weight has challenged
reliance on current weight to guide clinical concern.
WHAT THIS STUDY ADDS: Patients with large, rapid, or long-
duration of weight loss were more severely ill regardless of their
current weight. Weight history can help guide clinical concern for
pediatricians tasked with assessing restrictive eating disorders
in today’s diverse population of adolescents.
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Lower weight was traditionally
equated with more severe illness in
anorexia nervosa (AN). A higher index
of concern was supported by
extensive evidence associating low
weight with worse bradycardia and
hypotension,1,2 higher risk for
refeeding hypophosphatemia,3–6
lower bone mineral density,1
hematologic abnormalities,2 and
elevated liver enzymes.7 In addition
to more severe medical instability
and malnutrition, low weight was
required for a psychiatric diagnosis of
AN before 2013.8 Accurate
assessment of illness severity is
critical on hospital admission to
inform treatment decisions, such as
approaches to refeeding and
frequency of electrolyte
monitoring.9–12
Recognition of atypical anorexia
nervosa (AAN)8 has challenged
reliance on current weight to assess
illness severity. Patients with AAN
have eating disorder (ED)
psychopathology and significant
weight loss but are not underweight
relative to national norms. The
number of patients with AAN
requiring medical hospitalization has
risen sharply to comprise
approximately one-third of hospital
inpatient ED programs.13–15 In the
only available study to
comprehensively compare illness
severity in adolescents diagnosed
with AAN versus AN, Sawyer et al15
reported a greater magnitude of
weight loss over a longer period,
equal bradycardia and orthostasis,
and worse ED psychopathology.
Studies including normal-weight
patients with ED before the
recognition of AAN in 2013 have
reported similar findings.13,16,17
Weight suppression (WS), the
difference between premorbid and
presentation weight, has emerged
from the adult AN literature as
a marker of illness severity18 and
predictor of treatment outcomes.19
This is reflected in updated
recommendations, which now include
percentage of weight loss and time
frame in the assessment of
malnutrition.20,21 Studies of normal-
weight patients with ED before 2013
documented associations between
greater WS and worse
bradycardia,16,17 lower plasma
phosphate,17 and persistent
amenorrhea.22 Recently, Whitelaw
et al14 examined WS in AAN and
identified total and recent weight loss
as predictors of bradycardia
independent of presentation
weight.14 Although these findings
support WS as an indicator of medical
instability in AAN, the association
between WS and overall illness
severity requires examination. Other
weight history variables, including
rate and duration of loss, have not
been investigated in AAN. A faster
rate of weight loss has been examined
in normal-weight adolescents with ED
and associated with worse
bradycardia.17 Longer duration has
been examined extensively in AN and
associated with lower heart rate (HR),
systolic blood pressure (BP), and
bone mineral density.1,2 Our objective
in this study was to examine the
independent and collective
relationships between comprehensive
weight history (amount, rate, and
duration of loss) and medical,
nutritional, and psychological status.
We hypothesized that participants
with more dramatic weight losses
would be more severely ill on
hospitalization regardless of their
admission weight.
METHODS
Participants and Data Collection
Participants
Inclusion criteria were age 12 to
24 years, being admitted to the
hospital per Society for Adolescent
Health and Medicine criteria21 with
AN or AAN, and being .60% of the
median BMI (mBMI), defined as the
50th percentile BMI for age and sex.23
Because the Diagnostic and Statistical
Manual of Mental Disorders, Fifth
Edition does not identify a weight
threshold for AAN, mBMI .85% was
applied. Patients were excluded if
they were admitted to the hospital in
the previous 6 months, were
currently pregnant or diagnosed with
bulimia nervosa,8 or had chronic
disease, suicidality or psychosis.
Figure 1 shows that 301 patients met
inclusion criteria from February 2016
to March 2019, 120 enrolled in this
multicenter randomized clinical trial,
the Study of Refeeding to Optimize
Inpatient Gains (www.clinicaltrials.
gov; NCT02488109), and 181
declined, most commonly because
they preferred nonstudy treatment
(32%) or were uninterested in
research (21%). Four were ineligible
postenrollment, leaving a final count
of 116. Baseline data are reported
here, collected within 24 hours of
admission before the intervention.
Study sites included clinical centers at
the University of California, San
Francisco Benioff Children’s Hospital;
Lucile Packard Children’s Hospital at
Stanford; and the Data Coordinating
Center. The institutional review
boards at each site approved
the study.
Demographic Data
Race, ethnicity, and socioeconomic
information were self-reported by
participants and parents on
admission. Socioeconomic status
(SES) scores were derived from the
Hollingshead occupational index for
mother or primary parent (A.B.
Hollingshead, PhD, unpublished
observations, 1975), which is
validated as a single-factor approach
to derive SES.24
Weight and Menstrual History
Highest historical weight, height, and
last menstrual period and dates of
those measures were self-reported
by proctored questionnaire and
corroborated with parent reports,
growth records, and physician
history. Historical BMI was
calculated by using historical weight
and height; percentage mBMI was
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BMI divided by mBMI and multiplied
by 100.
ED Psychopathology
The Eating Disorder Examination
Questionnaire (EDE-Q)25 was self-
administered; scores range from 1 to
6, with higher scores indicating
greater severity.
Anthropometric, Vital Sign, and
Laboratory Data
Weight was measured on an
electronic mobile stand-on scale in
the morning, postvoiding and in
a gown only. Height was measured
once on a stadiometer. Oral
temperature was taken once per
day orally, automated BP and HR
measures were taken every 4 to
8 hours, night HR was measured
with continuous cardiac monitoring,
and postural changes of HR and BP
were assessed at least twice per day,
with supine measurements (after
5 minutes’ rest) followed by
standing measurements (after
2 minutes). When multiple
measures were taken within
24 hours, the most deviant value
(eg, lowest BP) was recorded. Blood
was drawn once by venipuncture
between 5:00 AM and 7:00 AM;
samples were analyzed on-site.
Statistical Methods
AN and AAN were compared with
unpaired t test results for continuous
variables or Fisher’s exact tests for
categorical variables (eg, race and/or
ethnicity). Associations between 3
weight history variables
(independent variables) and
indicators of illness severity on
admission (dependent variables)
were examined with multiple variable
regression models. (1) Amount of loss
was the change in the percentage of
mBMI from the highest historical
percentage of mBMI to the admission
percentage of mBMI. (2) Rate of loss
was the amount of loss divided by the
duration of weight loss. (3) Duration
of loss was the time (in months)
between the highest historical weight
and the date of admission. Models
were adjusted for admission
percentage of mBMI. Multivariable
linear regression, followed by
stepwise backward selection, was
used to examine the contribution of
comprehensive weight history on 3
illness severity outcomes used
clinically as indicators of medical
instability (HR), nutritional risk
(serum phosphorus), and
psychological symptoms (EDE-Q
global score). Weight history models
began with 10 independent variables:
all 8 weight history variables are
shown in Table 1 along with age and
admission percentage of mBMI in the
full study population. Amenorrhea
and weight history models began
with 11 independent variables: the
same 10 variables in the weight
history models plus duration of
amenorrhea. These analyses were
restricted to the 50 postmenarcheal
girls with $3 months since their last
menstrual period and who were not
taking hormonal contraception.
Collinear weight variables were
included to explain as much of the
variance in the outcome as possible.
Although collinearity affects
individual coefficients and P values, it
FIGURE 1
Flow of participants into the Study of Refeeding to Optimize Inpatient Gains.
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does not influence the precision of
the prediction or the goodness-of-fit
statistic.26 A significance level of 0.20
was set for variable removal to avoid
excluding potentially important
variables.
RESULTS
Description and Comparison of
Participants With AAN and AN
A total of 116 participants enrolled:
50 with AAN and 66 with AN. Table 1
compares the AAN and AN groups on
admission. The study population did
not differ from the wider clinical
inpatient ED population by key
demographic characteristics,
including age, sex, and race and/or
ethnicity.
Demographics
Participants were 16.5 6 2.6 years
old on average, 91% were of female
sex. Participants were predominantly
non-Hispanic white and Asian
American and of “average” SES
(defined as occupational score
.4.0),24 with no significant
differences seen between groups.
Weight and Menstrual History
Historical BMI (25.2 6 5.6 vs 20.7 6
3.0; P , .001) and percentage of
mBMI (129.2 6 28.8 vs 104.3 6 16.9;
P , .001) were higher in AAN than
AN. There were no significant
differences in weight history or
duration of amenorrhea. Absolute
weight loss was ∼13.5 kg over
a duration of ∼15.9 months at a rate
of 1.6 kg per month or 3.5%
per month.
ED Psychopathology
Psychological symptoms were
significantly greater in AAN than in
AN (3.80 6 1.66 vs 3.00 6 1.66; P =
.02), with a mean EDE-Q global score
in AAN .1 SD above the community
mean of 3.38.25 All subscale scores
except eating concerns were higher in
AAN (all P , .05).
TABLE 1 Characteristics of Study Participants on Admission, Including Demographics, Wt and
Menstrual History, ED Psychopathology, and Vital Sign and Laboratory Values
AAN (n = 50) AN (n = 66) P
Demographics
Age, y, mean 6 SD 16.3 6 2.6 16.7 6 2.5 .36
Female sex, % (n) 88 (44) 92 (61) .53
Race and/or ethnicity, % (n) .49
Non-Hispanic white 50 (25) 67 (44)
Asian American 12 (6) 12 (8)
Hispanic or Latino 26 (13) 17 (11)
Other or .1 race and/or ethnicity 12 (6) 5 (3)
Family history of ED, % 32 (16) 30 (20) .55
Socioeconomic score, mean 6 SD 4.83 6 3.8 5.27 6 3.0 .51
Wt and menstrual history
Highest historical BMI, mean 6 SD 25.2 6 5.6 20.7 6 3.0 ,.001
Highest historical % mBMI, mean 6 SD 129.2 6 28.8 104.3 6 15.9 ,.001
Wt loss, kg, mean 6 SD 14.5 6 12.0 12.7 6 6.7 .33
Wt loss, % of body wt, mean 6 SD 19.9 6 10.4 22.4 6 8.6 .16
Wt loss, % mBMI, mean 6 SD 33.8 6 25.9 27.9 6 15.5 .13
Duration of wt loss, mo, mean 6 SD 15.4 6 15.4 16.2 6 18.7 .79
Rate of loss, kg per mo, mean 6 SD 1.6 6 1.3 1.6 6 1.4 .95
Rate of % mBMI loss, % per mo, mean 6 SD 3.6 6 2.6 3.5 6 3.1 .84
Duration of amenorrhea, mo,a mean 6 SD 6.7 6 5.3 10.5 6 9.3 .10
No menses in 3 mo,a % (n) 77 (20) 86 (30) .81
ED psychopathology, EDE-Q score, mean 6 SD n = 42 n = 58
Global score 3.80 6 1.66 3.00 6 1.66 .02
Wt concerns 3.75 6 1.87 2.83 6 1.82 .02
Shape concerns 4.35 6 1.89 3.49 6 1.77 .02
Restraint 4.00 6 1.79 3.09 6 2.01 .02
Eating concerns 3.10 6 1.65 2.59 6 1.54 .12
Admission wt and vital signs, mean 6 SD
Admission % mBMI 95.2 6 9.0 76.5 6 5.9 ,.001
Lowest 24-h HR, beats per min 40.3 6 4.7 42.0 6 7.0 .15
Lowest SBP, mmHg 96.4 6 8.1 92.0 6 7.6 .004
Lowest temperature, °C 36.6 6 0.1 36.6 6 0.1 .99
Orthostatic change in HR, increase $20 beats per min 25.8 6 14.9 26.7 6 12.5 .74
Orthostatic change in systolic BP, decrease $10 mmHg 1.3 6 8.5 0.6 6 5.8 .63
Percent with vital sign instabilities, % (n)
Bradycardia, ,50 beats per min 96 (48) 89 (59) .17
Hypotension, systolic BP ,90 mmHg 18 (9) 41 (27) .009
Hypothermia, ,36.0°C 0 (0) 2 (1) .57
Orthostatic HR, increase $20 beats per min 54 (27) 65 (43) .23
Orthostatic systolic BP, decrease $10 mmHg 14 (7) 6 (4) .15
Admission laboratory values (reference range), mean 6 SD
Creatinine (0.50–0.80 mg/dL) 0.74 6 0.10 0.69 6 0.11 .08
AST (25–40 IU/L) 25.7 6 12.5 26.6 6 12.3 .72
ALT (20–50 IU/L) 23.9 6 12.1 33.1 6 26.7 .03
Phosphorus (3.0–5.1 mg/dL) 3.8 6 0.6 3.7 6 0.5 .48
Magnesium (1.8–2.4 mg/dL) 2.1 6 0.2 2.2 6 0.1 .27
Potassium (3.5–5.1 mmol/L) 3.8 6 0.3 3.8 6 0.4 .78
Percent with laboratory abnormalities, % (n)
High creatinine, .0.8 mg/dL 36 (18) 23 (15) .78
High AST, .40 IU/L 6 (3) 12 (8) .59
High ALT, .30 IU/L7 20 (10) 33 (22) .90
Hypophosphatemia, ,3.0 mg/dL3 6 (3) 6 (4) .65
Hypokalemia, ,3.5 mmol/L 14 (7) 14 (9) .58
Hypomagnesemia, ,1.8 mg/dL 8 (4) 0 (0) .03
The values presented as mean 6 SD have P values from independent 2-sample t tests; values presented as % (n) have P
values from Fisher’s exact tests. Reference ranges are taken from the Clinical Laboratory Improvement Amendment
laboratory manual for adolescents unless otherwise noted.
a Among postmenarcheal girls with $ 3 mo since their last menstrual period and who are not taking hormonal
contraception.
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Admission Weight, Vital Signs and
Laboratory Values
By definition, participants with AAN
had a significantly higher admission
percentage of mBMI than those with
AN (95.2 6 9.0 vs 76.5 6 5.9%; P ,
.001). There was no difference in the
lowest HR between groups (40.3 6
4.7 vs 42.0 6 7.0 beats per minute;
P = .15); 93% had an HR ,50 beats
per minute. Those with AAN had
higher systolic BP (96.4 6 8.1 vs 92.0
6 7.6 mmHg; P = .004) and were less
likely to present with hypotension
(systolic BP ,90 mmHg; 18% vs
41%, respectively; P = .009). Alanine
aminotransferase (ALT) was lower in
AAN (23.9 6 12.1 vs 33.1 6 26.7 IU/
L; P = .03). There were no differences
in serum electrolytes.
Association Between Individual
Weight History Variables and
Presentation Characteristics
Table 2 shows associations between 3
weight variables and illness severity.
Bivariate associations with admission
percentage of mBMI and markers of
illness severity are shown in the first
column (model 0). Higher admission
percentage of mBMI was associated
with lower HR, higher BP, lower ALT,
higher serum phosphorus, and higher
(worse) EDE-Q global scores (b =
0.042 [CI 0.013 to 0.070]; P = .004)
and all subscale scores except eating
concerns. Associations between
amount of loss (model 1), rate of loss
(model 2), and duration of loss
(model 3) and markers of illness
severity are shown, unadjusted and
adjusted for admission percentage of
mBMI. Significant findings from these
models are also depicted in Fig 2
(scatter plots with dots showing the
unadjusted relationship and a line
adjusted for admission percentage of
mBMI): greater percentage of mBMI
loss and lower serum phosphorus (b
= 20.005 [confidence interval (CI)
20.001 to 20.000]; P = .04); faster
rate of percentage of mBMI loss and
lower HR (b = 20.492 [CI 20.883 to
20.100]; P = .01) and lower aspartate
transaminase (AST) (b= 21.24 [CI
22.25 to 20.228]; P = .02); longer
duration of weight loss and lower
creatinine (b = 20.002 [CI 20.003 to
20.000]; P = .02); higher AST (b =
0.171 [CI 20.031 to 20.312]; P =
.02); and lower serum phosphorus (b
= 20.011 [CI 20.017 to 0.005]; P =
.001).
Predictive Value of Comprehensive
Weight History on Key Indicators of
Severity of Illness
Table 3 illustrates the results of
stepwise regression analyses.
Serum Phosphorus
In the weight history model, 3
variables contributed significantly to
the fit of the final model for serum
phosphorus: highest historical BMI,
percentage of body weight loss, and
duration of weight loss (in months).
The adjusted R2 for the final model
was 0.164. In the weight and
menstrual history model, 8 variables
contributed significantly to the fit:
highest historical BMI, age, amount of
weight loss (percentage of mBMI loss
and percentage of body weight loss),
admission percentage of mBMI,
duration of amenorrhea, and rate of
loss (percentage of mBMI loss per
month and kilograms lost per month).
The adjusted R2 for the final model
was 0.358.
HR
The weight history model retained 4
variables: highest historical
percentage of mBMI, age, and amount
of weight lost (percentage of mBMI
loss and kilograms lost). The adjusted
R2 was 0.093. The weight and
menstrual history model retained 6
variables: highest historical
percentage of mBMI, BMI, age,
amount of percentage of mBMI loss
and kilograms lost, and duration of
amenorrhea. The final model adjusted
R2 was 0.278.
EDE-Q Global Score
The weight history model retained 5
variables: highest historical
percentage of mBMI, BMI, age,
admission percentage of mBMI, and
amount of percentage of mBMI loss.
The final model adjusted R2 was
0.202. The weight and menstrual
history model retained 4 variables:
highest historical percentage of
mBMI, BMI, age, and duration of
amenorrhea. The final model adjusted
R2 was 0.091.
DISCUSSION
Adolescents admitted to the hospital
with AAN or AN who experienced
a greater amount, rate, or duration of
weight loss had significantly worse
medical and nutritional status
independent of admission weight.
These findings build on 1 previous
study of WS in AAN, in which
a greater amount and recency of
weight loss predicted lower HR.14 The
marked rise in adolescents with AAN
requiring hospitalization at
apparently normal weights13–15 has
challenged the historical reliance on
current weight to guide clinical
concern. Bradycardia is a primary
indicator for medical
hospitalization,21 and cardiac
arrhythmia with electrolyte
disturbances contribute to increased
mortality in AN.27 In the current
study population, faster rate of
weight loss before hospitalization
predicted lower HR at admission
across both diagnoses and all body
weights. This finding supports the
need for early intervention regardless
of body weight.
Numerous hormonal and metabolic
adaptations to starvation were
documented in weight-reduced
subjects with obesity28,29 and low-
weight patients with AN as long as
20 years ago.30 More recently, WS
has gained traction as a potential
marker of illness severity18 and
predictor of treatment outcomes in
adults with AN.19 Before the
recognition of AAN, studies including
normal-weight patients with ED
reported lower HR in those with
larger amounts of 16 or faster weight
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losses.17 Whitelaw et al14 recently
confirmed this in patients with AAN.
Contrary to their results, we did not
find a relationship between WS and
HR, although we did find a robust
association with rate of weight loss:
for every 2% mBMI per month faster
loss, HR was 1 beat per minute lower
on admission. These findings suggest
that HR is sensitive to acute
nutritional insult even if weight
remains normal.
The timing of malnutrition is salient
in adolescents because of the
advanced nutritional demands of
growth and puberty.31 We found that
participants with AAN were just as
likely to have amenorrhea as those
with AN. One study identified WS as
a predictor of prolonged amenorrhea
during follow-up of formerly
overweight patients with ED,22
suggesting that hypothalamic-
pituitary-gonadal suppression due to
malnutrition in AN30 can also result
from WS. We examined the
explanatory value of weight history
on illness severity with and without
the menstrual history. For HR, the
variance explained by weight history
increased dramatically from 9% to
28% when duration of amenorrhea
was added. For serum phosphorus,
model fit improved from 16% to 36%.
For context, stepwise regression
models of powerful cardiovascular
risk factors (eg, smoking) explain
52% of the variance in disease
outcomes.32 Thus, among
postmenarcheal girls, weight and
menstrual history contribute
meaningfully to the assessment of
medical and nutrition status. The
interactive effects of weight history
and pubertal stage on medical and
nutritional status require further
investigation.
Our main finding related to WS is that
participants who had lost greater
amounts had lower serum
phosphorus on admission regardless
of admission weight. The possibility
that normal-weight patients could be
at increased risk during refeedingTA
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challenges the historical thinking that
low-weight patients warranted the
most concern.3–6 Although our study
was limited to baseline, Whitelaw
et al14 followed patients during
refeeding and found that greater WS
predicted lower phosphate nadir.
Together these findings support
consideration of WS to determine
which patients may need more
cautious refeeding or intensive
medical monitoring. For
decades, lower-calorie refeeding
was applied broadly to ensure the
safety of all patients.33 However,
this approach is linked to poor
weight gain and protracted
hospital stay,9,10,12 and clinical
practice is moving toward more
aggressive refeeding. The need for
new tools to assess risk in today’s
inpatient population with diverse
diagnoses and body weights13–15 is
pressing.
ED psychopathology was significantly
worse in AAN, in accordance with
Sawyer et al.15 Higher EDE-Q scores
were consistently associated with
higher admission weight but not
weight history. This had not been
previously examined in adolescents,
aside from a subanalysis by Whitelaw
FIGURE 2
Significant associations between weight history variables and markers of illness severity. Dots depict the unadjusted association between the weight loss
variable and marker of illness severity for each participant. The line illustrates the predicted relationship from multivariable linear regression adjusted
for admission percentage of mBMI. b coefficients with 95% CIs, P values, and adjusted R2 from adjusted multivariable linear regression are shown.
Findings were as follows. Lowest serum phosphorous (amount): b = 2.005 (95% CI 2.010 to .000); P = .04; adjusted R2 = 0.074. AST (duration): b = .171
(95% CI .031 to .312); P = .02; adjusted R2 = 0.076. AST (rate): b = 21.24 (95% CI 22.25 to .228); P = .02; adjusted R2 = 0.076. Serum creatinine: b = 2.002
(95% CI 2.003 to 2.000); P = .01; adjusted R2 = 0.044. Lowest HR: b = 2.492 (95% CI 2.883 to 2.100); P = .01; adjusted R2 = 0.070. Lowest serum
phosphorous (duration): b = 2.011 (95% CI 2.017 to2.005); P = .001; adjusted R2 = 0.044.
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et al.14 The lack of association was
striking given the relationship
between greater WS and worse ED
psychopathology in the adult
literature.18,19 In stepwise regression,
weight history explained 20% of the
variance in EDE-Q global scores, and
model fit was reduced by adding
amenorrhea, suggesting that other
factors powerfully influence ED
psychopathology in postmenarcheal
girls. Nevertheless, the reproducible
finding that patients with AAN have
worse ED psychopathology continues
to dispel the misconception that AAN
is a lesser illness than AN and
heightens the need to examine
whether there are ED cognitions or
behaviors that are unique to AAN.
Duration of weight loss had not been
previously examined in AAN. It is
clear that severity increases with
duration of AN,1,2 underscoring the
importance of early intervention. A
longer duration of weight loss was
associated with lower serum
phosphorus, lower creatinine, and
higher AST regardless admission
weight. As to how these markers may
indicate nutritional status, serum
creatinine is decreased in
malnutrition related to lean mass
wasting,34 which contributes to
hypophosphatemia.35 Although
creatinine must be interpreted with
caution in AN,36 our findings suggest
that relative reductions in lean mass
are detrimental to nutritional status
even if total lean mass remains
normal, as shown in AAN.37
Aminotransferases were of interest as
markers of malnutrition; they are
elevated in roughly one-third of
patients with AN7 and rise in
proportion to lower weight7,38 and fat
mass.7 Accordingly, we found
elevated ALT in 30% of participants
with AN, increasing in proportion to
lower weight. ALT was significantly
lower in the AAN group but increased
with longer duration, suggesting that
the relatively higher fat mass
documented in AAN37 is
hepatoprotective during early weight
loss. Studies should examine whether
there are tissue-specific effects of
weight loss related to body
composition.
We acknowledge several limitations.
First, patients at ,60% mBMI were
excluded; findings cannot be
generalized to patients of extremely
low weight. Second, we do not report
medication and alcohol use, which
could impact measures such
aminotransferases.7 Third,
examinations of menstrual status
were limited to the 43% of
participants who were
postmenarcheal girls. Fourth, these
baseline data cannot be extrapolated
to inform risk during refeeding. Fifth,
although self-reported weight is more
accurate in AN than in other
diagnoses,39 it is less reliable than
objective measurement. Finally,
participants were already identified
or referred to our ED specialty
programs and subsequently
hospitalized, making measures such
as telemetry feasible. However,
weight histories were collected by
questionnaire and could be
performed by pediatricians in any
clinical setting to help guide clinical
concern and make treatment
decisions (eg, whether to refer for
specialty care).
CONCLUSIONS
Assessment of patients with AN has
traditionally relied on current weight,
with the highest index of concern
being for low-weight patients. Our
findings support concern for patients
with large, fast, and/or long-duration
weight loss even if current weight
remains normal. Future research is
needed to examine the use of weight
history to inform treatment decisions
and outcomes.
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